149 related articles for article (PubMed ID: 15966776)
1. Investigating the evaporation of metered-dose inhaler formulations in humid air: single droplet experiments.
Martin AR; Kwok DY; Finlay WH
J Aerosol Med; 2005; 18(2):218-24. PubMed ID: 15966776
[TBL] [Abstract][Full Text] [Related]
2. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
[TBL] [Abstract][Full Text] [Related]
3. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
4. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
[TBL] [Abstract][Full Text] [Related]
5. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
Sheth P; Stein SW; Myrdal PB
Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
Marijani R; Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
[TBL] [Abstract][Full Text] [Related]
7. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Peyron ID; Britto IL; Benissan LB; Tardieu BZ
Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
[TBL] [Abstract][Full Text] [Related]
8. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
Smyth HD; Hickey AJ
AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
[TBL] [Abstract][Full Text] [Related]
9. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects.
Kempsford R; Handel M; Mehta R; De Silva M; Daley-Yates P
Respir Med; 2005 Apr; 99 Suppl A():S11-9. PubMed ID: 15777604
[TBL] [Abstract][Full Text] [Related]
11. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
Zhu B; Traini D; Chan HK; Young PM
Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
[TBL] [Abstract][Full Text] [Related]
12. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
Kleinstreuer C; Shi H; Zhang Z
J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
[TBL] [Abstract][Full Text] [Related]
13. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
Pu Y; Kline LC; Berry J
Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
[TBL] [Abstract][Full Text] [Related]
14. Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.
Tiwari D; Goldman D; Dixit S; Malick WA; Madan PL
Drug Dev Ind Pharm; 1998 Apr; 24(4):345-52. PubMed ID: 9876594
[TBL] [Abstract][Full Text] [Related]
15. Drug form selection in albuterol-containing metered-dose inhaler formulations and its impact on chemical and physical stability.
Tzou TZ; Pachuta RR; Coy RB; Schultz RK
J Pharm Sci; 1997 Dec; 86(12):1352-7. PubMed ID: 9423144
[TBL] [Abstract][Full Text] [Related]
16. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
Abdou EM; Kandil SM; Morsi A; Sleem MW
Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
[TBL] [Abstract][Full Text] [Related]
17. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
18. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers.
Ju D; Shrimpton J; Hearn A
Int J Pharm; 2010 May; 391(1-2):221-9. PubMed ID: 20227471
[TBL] [Abstract][Full Text] [Related]
19. Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics.
Selvam P; Bharatwaj B; Porcar L; da Rocha SR
Int J Pharm; 2012 Jan; 422(1-2):428-35. PubMed ID: 22044539
[TBL] [Abstract][Full Text] [Related]
20. How to engineer aerosol particle properties and biopharmaceutical performance of propellant inhalers.
Akhuemokhan P; Green NA; Haddrell A; Lewis D; Reid JP; Forbes B
Int J Pharm; 2023 Mar; 634():122676. PubMed ID: 36738807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
